PHOENIX ASIA HOLDINGS LTD (PHOE) Stock Fundamental Analysis

NASDAQ:PHOE • KYG7075R1083

13.5 USD
-0.55 (-3.91%)
Last: Feb 20, 2026, 01:45 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall PHOE gets a fundamental rating of 5 out of 10. We evaluated PHOE against 55 industry peers in the Construction & Engineering industry. PHOE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. PHOE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year PHOE was profitable.
  • PHOE had a positive operating cash flow in the past year.
PHOE Yearly Net Income VS EBIT VS OCF VS FCFPHOE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 0 200K 400K 600K 800K 1M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 19.11%, PHOE belongs to the top of the industry, outperforming 92.73% of the companies in the same industry.
  • PHOE's Return On Equity of 33.00% is amongst the best of the industry. PHOE outperforms 83.64% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 34.07%, PHOE belongs to the top of the industry, outperforming 94.55% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for PHOE is significantly above the industry average of 16.93%.
  • The last Return On Invested Capital (34.07%) for PHOE is well below the 3 year average (44.64%), which needs to be investigated, but indicates that PHOE had better years and this may not be a problem.
Industry RankSector Rank
ROA 19.11%
ROE 33%
ROIC 34.07%
ROA(3y)23.2%
ROA(5y)N/A
ROE(3y)49.56%
ROE(5y)N/A
ROIC(3y)44.64%
ROIC(5y)N/A
PHOE Yearly ROA, ROE, ROICPHOE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 20 40 60

1.3 Margins

  • The Profit Margin of PHOE (13.92%) is better than 92.73% of its industry peers.
  • PHOE has a better Operating Margin (17.61%) than 96.36% of its industry peers.
  • With an excellent Gross Margin value of 29.52%, PHOE belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
Industry RankSector Rank
OM 17.61%
PM (TTM) 13.92%
GM 29.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHOE Yearly Profit, Operating, Gross MarginsPHOE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHOE is creating value.
  • PHOE has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, PHOE has an improved debt to assets ratio.
PHOE Yearly Shares OutstandingPHOE Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 5M 10M 15M 20M
PHOE Yearly Total Debt VS Total AssetsPHOE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 1M 2M 3M 4M 5M

2.2 Solvency

  • PHOE has an Altman-Z score of 84.09. This indicates that PHOE is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 84.09, PHOE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • PHOE has a debt to FCF ratio of 0.02. This is a very positive value and a sign of high solvency as it would only need 0.02 years to pay back of all of its debts.
  • PHOE's Debt to FCF ratio of 0.02 is amongst the best of the industry. PHOE outperforms 92.73% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that PHOE is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.00, PHOE belongs to the best of the industry, outperforming 89.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Altman-Z 84.09
ROIC/WACC3.56
WACC9.56%
PHOE Yearly LT Debt VS Equity VS FCFPHOE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 1M 2M 3M

2.3 Liquidity

  • PHOE has a Current Ratio of 2.24. This indicates that PHOE is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of PHOE (2.24) is better than 90.91% of its industry peers.
  • A Quick Ratio of 2.24 indicates that PHOE has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 2.24, PHOE belongs to the best of the industry, outperforming 92.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 2.24
PHOE Yearly Current Assets VS Current LiabilitesPHOE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 1M 2M 3M 4M 5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for PHOE have decreased by -2.86% in the last year.
  • PHOE shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.06%.
EPS 1Y (TTM)-2.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.86%
Revenue 1Y (TTM)28.06%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.06%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PHOE Yearly Revenue VS EstimatesPHOE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2M 4M 6M

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 270.00 indicates a quite expensive valuation of PHOE.
  • 70.91% of the companies in the same industry are cheaper than PHOE, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.09. PHOE is valued rather expensively when compared to this.
Industry RankSector Rank
PE 270
Fwd PE N/A
PHOE Price Earnings VS Forward Price EarningsPHOE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHOE indicates a slightly more expensive valuation: PHOE is more expensive than 72.73% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHOE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 255.95
EV/EBITDA 226.66
PHOE Per share dataPHOE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3

4.3 Compensation for Growth

  • PHOE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PHOE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHOENIX ASIA HOLDINGS LTD

NASDAQ:PHOE (2/20/2026, 1:45:11 PM)

13.5

-0.55 (-3.91%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.09%
Inst Owner ChangeN/A
Ins Owners74.54%
Ins Owner ChangeN/A
Market Cap291.60M
Revenue(TTM)7.37M
Net Income(TTM)1.03M
AnalystsN/A
Price TargetN/A
Short Float %0.31%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 270
Fwd PE N/A
P/S 39.56
P/FCF 255.95
P/OCF 247.04
P/B 93.76
P/tB 93.76
EV/EBITDA 226.66
EPS(TTM)0.05
EY0.37%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.05
FCFY0.39%
OCF(TTM)0.05
OCFY0.4%
SpS0.34
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.4
Profitability
Industry RankSector Rank
ROA 19.11%
ROE 33%
ROCE 41.45%
ROIC 34.07%
ROICexc 141.42%
ROICexgc 141.42%
OM 17.61%
PM (TTM) 13.92%
GM 29.52%
FCFM 15.46%
ROA(3y)23.2%
ROA(5y)N/A
ROE(3y)49.56%
ROE(5y)N/A
ROIC(3y)44.64%
ROIC(5y)N/A
ROICexc(3y)115.11%
ROICexc(5y)N/A
ROICexgc(3y)115.11%
ROICexgc(5y)N/A
ROCE(3y)54.33%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Debt/EBITDA 0.01
Cap/Depr 133.44%
Cap/Sales 0.56%
Interest Coverage 1622.12
Cash Conversion 88.85%
Profit Quality 111.01%
Current Ratio 2.24
Quick Ratio 2.24
Altman-Z 84.09
F-Score6
WACC9.56%
ROIC/WACC3.56
Cap/Depr(3y)79.85%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.52%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.06%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y110.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.47%
OCF growth 3YN/A
OCF growth 5YN/A

PHOENIX ASIA HOLDINGS LTD / PHOE FAQ

Can you provide the ChartMill fundamental rating for PHOENIX ASIA HOLDINGS LTD?

ChartMill assigns a fundamental rating of 5 / 10 to PHOE.


Can you provide the valuation status for PHOENIX ASIA HOLDINGS LTD?

ChartMill assigns a valuation rating of 1 / 10 to PHOENIX ASIA HOLDINGS LTD (PHOE). This can be considered as Overvalued.


Can you provide the profitability details for PHOENIX ASIA HOLDINGS LTD?

PHOENIX ASIA HOLDINGS LTD (PHOE) has a profitability rating of 7 / 10.


What is the valuation of PHOENIX ASIA HOLDINGS LTD based on its PE and PB ratios?

The Price/Earnings (PE) ratio for PHOENIX ASIA HOLDINGS LTD (PHOE) is 270 and the Price/Book (PB) ratio is 93.76.


Can you provide the financial health for PHOE stock?

The financial health rating of PHOENIX ASIA HOLDINGS LTD (PHOE) is 9 / 10.